Modified-release Dipyridamole/Aspirin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Modified-release Dipyridamole/Aspirin, covering 2025-01-23 to 2025-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients [Phase 4]